Teladoc Revenue vs. Cash And Equivalents
| TDOC Stock | USD 11.98 0.55 4.81% |
Total Revenue | First Reported 2013-12-31 | Previous Quarter 642.4 M | Current Value 640.5 M | Quarterly Volatility 258.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.78 | 0.708 |
|
|
For Teladoc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Teladoc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Teladoc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Teladoc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Teladoc over time as well as its relative position and ranking within its peers.
Teladoc |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share 15.333 | Quarterly Revenue Growth (0.03) | Return On Assets (0.03) | Return On Equity (0.52) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Teladoc Cash And Equivalents vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Teladoc's current stock value. Our valuation model uses many indicators to compare Teladoc value to that of its competitors to determine the firm's financial worth. Teladoc is currently regarded number one company in revenue category among its peers. It also is currently regarded as top stock in cash and equivalents category among its peers creating about 0.34 of Cash And Equivalents per Revenue. The ratio of Revenue to Cash And Equivalents for Teladoc is roughly 2.94 . At present, Teladoc's Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teladoc's earnings, one of the primary drivers of an investment's value.Teladoc's Earnings Breakdown by Geography
Teladoc Revenue vs. Competition
Teladoc is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 5.33 Billion. Teladoc totals roughly 2.6 Billion in revenue claiming about 49% of equities under Health Care industry.
Teladoc Cash And Equivalents vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Teladoc |
| = | 2.6 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Teladoc |
| = | 883.7 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Teladoc Cash And Equivalents Comparison
Teladoc is currently under evaluation in cash and equivalents category among its peers.
Teladoc Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Teladoc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Teladoc will eventually generate negative long term returns. The profitability progress is the general direction of Teladoc's change in net profit over the period of time. It can combine multiple indicators of Teladoc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -37 M | -35.1 M | |
| Operating Income | -248.6 M | -261 M | |
| Income Before Tax | -219.6 M | -230.6 M | |
| Total Other Income Expense Net | 28.9 M | 30.4 M | |
| Net Loss | -220.4 M | -231.4 M | |
| Income Tax Expense | 760 K | 798 K | |
| Net Loss | -220.4 M | -231.4 M | |
| Net Loss | -12.3 B | -11.7 B | |
| Interest Income | 46.8 M | 49.1 M | |
| Net Interest Income | 24.5 M | 25.7 M | |
| Non Operating Income Net Other | -987.9 K | -1 M | |
| Change To Netincome | 15.7 B | 16.5 B | |
| Net Loss | (1.36) | (1.43) | |
| Income Quality | (1.59) | (1.51) | |
| Net Income Per E B T | 1.00 | 1.09 |
Teladoc Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Teladoc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Teladoc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Teladoc's important profitability drivers and their relationship over time.
Use Teladoc in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Teladoc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teladoc will appreciate offsetting losses from the drop in the long position's value.Teladoc Pair Trading
Teladoc Pair Trading Analysis
The ability to find closely correlated positions to Teladoc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Teladoc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Teladoc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Teladoc to buy it.
The correlation of Teladoc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Teladoc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Teladoc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Teladoc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Teladoc position
In addition to having Teladoc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
To fully project Teladoc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Teladoc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Teladoc's income statement, its balance sheet, and the statement of cash flows.